Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial is to evaluate the efficacy and safety of the WST09-mediated
vascular-targeted photodynamic therapy (VTP) in patients with localized prostate cancer
recurrent after external radiation therapy or temporary (High Dose Rate, or HDR)
brachytherapy.